Useful resources |
Neoadjuvant cisplatin for advanced bladder cancer (Cochrane Review) ABSTRACT Background: Bladder cancer is the second most common malignancy of the genito-urinary system. During the past 20 years many phase II clinical trials have investigated the role of chemotherapy in patients with locally advanced bladder cancer. These studies have i . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |